Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. (TRDA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TRDA · as of Jun 8, 2026
Key Statistics
Explore Entrada Therapeutics, Inc. Data
trda stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 60.0%
The TRDA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $16.00, representing +155.59% upside from the current price of $6.26.
Competitors & Peers
trda competitorsTRDA
ACHV
ALLO
ARCT
AVIR
CAPRStock Performance
Full HistoryAbout Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailmen…
what is entrada therapeutics, inc. · trda stock overview · entrada therapeutics, inc. company profile · who is entrada therapeutics, inc. ceo · trda NASDAQ · entrada therapeutics, inc. headquarters · entrada therapeutics, inc. business segments
About Stock Overview & Key Data
Entrada Therapeutics, Inc. (TRDA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 29, 2021. As of the latest trading session, TRDA stock price is $6.26, with a market capitalization of $243.0M. The stock has returned -22.81% over the past 12 months and -39.11% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Entrada Therapeutics, Inc. stock is Buy, with an average 12-month price target of $16.00. In fiscal year 2025, Entrada Therapeutics, Inc. reported revenue of $25.4M and net income of -$143.8M. For detailed data — including Entrada Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Entrada Therapeutics, Inc. (TRDA) stock price is $6.26. The stock is traded on NASDAQ under the ticker symbol TRDA. The 52-week range is $4.93 – $16.45.